Natera DSO Ratio 2011-2026 | NTRA

Annual DSO Ratio Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
81.5	58.5	61.6	64.4	88.1	14.3	22.5	11.2	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
88.1	11.2	50.3

Quarterly DSO Ratio Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60.7	-	-	-	-	-	68.1	-	60.8	60.3	49.8	-	73	82.9	64	58.5	62.5	65.5	78.9	84.8	87	90	77.8	74.8	71	75	55.9	24.8	22.7	23.5	14.2	10.1	11.3	11.3	11.3	10.9	5.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
90	5.86	51.6

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Agilent Technologies A	63.8	$ 119.97	0.82 %	$ 36.5 B	USA
Anixa Biosciences ANIX	275	$ 2.96	4.59 %	$ 96.1 K	USA
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	31.7	$ 22.65	-3.78 %	$ 237 M	China
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Castle Biosciences CSTL	49.2	$ 28.34	2.79 %	$ 787 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Charles River Laboratories International CRL	65	$ 179.2	1.92 %	$ 8.88 B	USA
Fulgent Genetics FLGT	77.4	$ 14.0	1.53 %	$ 423 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Biodesix BDSX	41.7	$ 14.83	-4.32 %	$ 1.92 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
IDEXX Laboratories IDXX	43.5	$ 650.18	2.3 %	$ 52.3 B	USA
Illumina ILMN	61.3	$ 129.26	-0.23 %	$ 20.6 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	83.4	$ 1.15	2.68 %	$ 1.46 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 208.68	0.16 %	$ 23.2 B	USA
Danaher Corporation DHR	55.3	$ 204.99	0.47 %	$ 146 B	USA
Organovo Holdings ONVO	79.8	-	-2.3 %	$ 19.4 M	USA
Exact Sciences Corporation EXAS	30.8	$ 103.52	0.15 %	$ 19.5 B	USA
Bioventus BVS	92.3	$ 8.57	-2.0 %	$ 537 M	USA
DarioHealth Corp. DRIO	85.8	$ 9.51	-7.67 %	$ 270 M	Israel
DexCom DXCM	87	$ 73.23	0.21 %	$ 28.6 B	USA
PerkinElmer PKI	92.2	-	-0.91 %	$ 14.7 B	USA
Psychemedics Corporation PMD	61.3	-	-1.84 %	$ 15.3 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Quotient Limited QTNT	45.1	-	-11.32 %	$ 1.1 M	Schweiz
ICON Public Limited Company ICLR	68.5	$ 110.76	1.89 %	$ 9.14 B	Irlanda
Renalytix AI plc RNLX	15.9	-	5.66 %	$ 22.7 M	Britain
CareDx, Inc CDNA	51.5	$ 19.25	2.37 %	$ 1.03 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 281.56	-0.53 %	$ 23.4 B	USA
Lantheus Holdings LNTH	80.5	$ 77.63	-1.53 %	$ 5.24 B	USA
Guardant Health GH	46.1	$ 93.91	0.65 %	$ 11.8 B	USA
IQVIA Holdings IQV	73.9	$ 176.67	1.53 %	$ 30.4 B	USA
Mettler-Toledo International MTD	66.4	$ 1 299.09	-1.29 %	$ 26.8 B	Schweiz
Co-Diagnostics CODX	101	-	-	$ 79.8 M	USA
Myriad Genetics MYGN	52.3	$ 5.36	1.23 %	$ 496 M	USA